Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
1.420
+0.020 (1.43%)
At close: Jun 18, 2025, 4:00 PM
1.440
+0.020 (1.41%)
After-hours: Jun 18, 2025, 6:27 PM EDT

Aclaris Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts that cover Aclaris Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $9.71, which forecasts a 583.8% increase in the stock price over the next year. The lowest target is $7 and the highest is $16.

Price Target: $9.71 (+583.8%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $9.71 $8.00 $16
Change +392.96% +583.80% +463.38% +1026.8%

Analyst Ratings

The average analyst rating for Aclaris Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 333333
Buy 224455
Hold 000000
Sell 000000
Strong Sell 000000
Total 557788

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wedbush
Wedbush
Buy
Initiates
$8
Buy Initiates $8 +463.38% May 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$20$16
Strong Buy Maintains $20$16 +1,026.76% May 14, 2025
Scotiabank
Scotiabank
Buy
Maintains
$15$9
Buy Maintains $15$9 +533.80% May 9, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Mar 18, 2025
Scotiabank
Scotiabank
Buy
Initiates
$15
Buy Initiates $15 +956.34% Mar 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
6.10M
from 18.72M
Decreased by -67.41%
Revenue Next Year
6.82M
from 6.10M
Increased by 11.77%
EPS This Year
-0.56
from -1.71
EPS Next Year
-0.62
from -0.56
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
6.48M6.76M29.75M31.25M18.72M6.10M6.82M7.38M
Revenue Growth
53.35%4.30%340.05%5.03%-40.09%-67.41%11.77%8.17%
EPS
-1.20-1.60-1.33-1.27-1.71-0.56-0.62-0.62
EPS Growth
--------
Forward PE
--------
No. Analysts
-----997
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 10.1M 10.5M 9.3M
Avg 6.1M 6.8M 7.4M
Low 3.0M 3.0M 5.7M

Revenue Growth

Revenue Growth 20252026202720282029
High
-46.2%
72.1%
37.1%
Avg
-67.4%
11.8%
8.2%
Low
-83.8%
-50.2%
-16.3%

EPS Forecast

EPS 20252026202720282029
High -0.53 -0.54 -0.37
Avg -0.56 -0.62 -0.62
Low -0.61 -0.70 -0.88

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.